Showing posts with label 2013 Meeting Agenda. Show all posts
Showing posts with label 2013 Meeting Agenda. Show all posts

Saturday, July 6, 2013

West Virginia Board of Pharmacy July 8, 2013 Meeting Agenda


Morgantown, West Virginia
Sunday, July 7, 2013
5:00 P.M.  Marriott Residence Inn, Conference room.
1. Approval of March 24-25, 2013, Board Minutes.
2. Complaint Committee disciplinary recommendations. (Executive Session: Complaint
Committee to address).
3. West Virginia Pharmacist Recovery Network de-identified case discussion (Executive
Session; patient not to be identified before the Board to maintain confidentiality of
identity; Mike Brown to present).
4. Annual employee and salary/per diem reviews.  (Executive Session)
Recess.
Continue meeting on 7/8/13 at 8:00 a.m., at WVU School of Pharmacy, Room 1131 Conference
Room.
{Amended 7/1/13}2 | P a g e West Virginia Board of Pharmacy, 106 Capitol Street, Charleston, West Virginia
Re-convene Monday, July 8, 2013
Morgantown, West Virginia
8:00 A.M.  WVU School of Pharmacy, Rm 1131
Continued from 7/7/13
5. Building Renovation Update.  Contract awarded and work begun.
6. CAMC Request of CAMC Solutions Pharmacy (Compounding Pharmacy) to contract
with Infusion Solutions to provide home infusion pharmacy services from CAMC
Solutions.
7. Consider amendments (by emergency rule) to Title 15, Series 8 of the WV Code of State
Rules to clarify reporting requirements consistent with ASAP 4.2 format used by the new
CSMP database (e.g., permitting an official identification card number to be reported to
satisfy for reporting the address and date of birth of a person picking up a prescription on
behalf of a patient, since an investigator can run the ID number).
8. Consider policy and rules amendments to pharmacist internship and experiential
education requirements for licensure.
9. Consider rules amendments for pharmacy technician registration with regard to
grandfathering of current registrants and registration of new registrants as of July 1, 2014,
due to new Larry Border Pharmacy Practice Act changes.
10. Consider setting by policy date on which Board will begin enforcing requirement for the
PIC of out-of-state mail order pharmacies to have WV pharmacist license  due to new
Larry Border Pharmacy Practice Act changes.
11. Consider request of CVS  Caremark for CVS Specialty Pharmacies for  a waiver from
central fill, remote dispensing, and any other rules necessary to permit a model for
delivery of specialty medications by mail from the CVS Specialty Pharmacy to a local
CVS pharmacy for pickup by the patient (Susan DelMonico).
12. Consider Rule 15-7-4.1 request of Charleston Area Medical Center to approve ASHP
training program for pharmacy technician trainees.
13. Attendees and Delegate Selection at upcoming NABP District Meeting, October 17-19,
2013, Bar Harbor, Maine.
14. Consider attendance at (a) National Association of Chain Drug Stores “NACDS Total
Store Expo”, August 10-13, 2013, Las Vegas, NV; and/or
(b) National Community Pharmacists Association Annual Convention and Trade
Exposition, October 12-16, 2013, Orlando, Florida.
15. Election of Board Officers
16. Any other business.
17. Schedule of next Board Meeting.

Wednesday, June 12, 2013

Delaware Board of Pharmacy June 19, 2013 Meeting Agenda


PUBLIC MEETING NOTICE: BOARD OF PHARMACY
DATE AND TIME: Wednesday, June 19, 2013 9:30 a.m.
PLACE: 861 Silver Lake Boulevard, Dover, Delaware  Conference Room A , second floor of the Cannon Building

AGENDA (amended items are marked with an asterisk*)  
1.0 Call to Order
2.0 Review and Approval of Minutes
2.1 Meeting Minutes – May 15, 2013
3.0 President’s Report
4.0 Unfinished Business
 4.1 Complaint Status
  13-03-11 – Assigned to Hearing Officer   13-09-11 – Assigned to Hearing Officer   13-12-11 – Forwarded to Office of Attorney General   13-19-11 – Forwarded to Office of Attorney General   13-02-12 – Forwarded to Office of Attorney General   13-03-12 – Closed   13-04-12 – Assigned   13-05-12 – Assigned   13-07-12 – Assigned   13-09-12 – Assigned   13-01-13 – Forwarded to Office of Attorney General   13-02-13 – Assigned   13-03-13 – Assigned   13-04-13 – Assigned   13-05-13 – Assigned   13-06-13 – Forwarded to Office of Attorney General   13-07-13 – Assigned   13-08-13 – Assigned   13-09-13 – Assigned   13-10-13 – Assigned   13-11-13 – Assigned
 4.2 Prescription Monitoring Program (PMP) Update
4.3 Deliberation on Public Comments Received on Proposed Regulations  
 4.4 Discussion of Patient Counseling Regulation and Statute Language  
5.0 New Business 
 5.1 Pharmacist Licensure Approval Ratifications 
 5.1.1 Rina Kelley  5.1.2 Na’Teka Shelton  5.1.3 Chad Forinash  5.1.4 David Dinh  5.1.5 Gary Sobocinski  
 5.2 Pharmacist Intern Licensure Approval Ratifications 
  5.2.1 Viha Dave   5.2.2 Robert Wright   5.2.3 Laura Wolfe     5.3 Facility Licensure Approval Ratifications 
 5.3.1 Non–Resident Pharmacies 
   5.3.1.1 Green Valley Drugs    5.3.1.2 Goot Nursing Home Pharmacy, Inc.    5.3.1.3 Walgreen Co.     5.3.1.4 Mead Square Pharmacy, Inc.    5.3.1.5 Prescription Dynamics, Inc.    5.3.1.6 Arrow Pharmacy Holdings, LLC    5.3.1.7 HomeChoice Partners, Inc.  
 5.3.2 Wholesale Distributors 
   5.3.2.1 DPT Laboratories, Ltd.    5.3.2.2 Antigen Laboratories    5.3.2.3 Watson Pharma, Inc.     5.3.2.4 Grifols USA, LLC  
  5.3.3 Retail Pharmacies 
   5.3.3.1 Delaware CVS pharmacy    5.3.3.2 CVS Pharmacy #6869  
  5.3.4 Medical Gas Dispensers  
   5.3.4.1 Tri County Medical Equipment & Supply    5.3.4.2 Personal Support Medical Suppliers  
 5.4 Pharmacist-In-Charge Interview 
  5.4.1 Vinaykumar Prajapati   5.4.2 Vikas Verma  
 5.5 Consultant Pharmacist Interview 
  5.5.1 Joshua Coffield 
Board of Pharmacy Agenda – June 19, 2013 Page 3     
6.0   Committee Reports 
 6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David        Dryden  
 6.2 Continuing Education – Sandy Robinson and Joli Martini  
 6.3 Consumer Affairs – Matt Maher and Jay Galloway  
 6.4 Professional Liaisons – Sandy Robinson and Sandra Zaragoza  
6.5 Controlled Substance Liaisons – Howard Simon, Jay Galloway and David Dryden  
7.0 Committee Updates Regarding Proposed Regulations 
 7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Sandra Zaragoza, Hooshang Shanehsaz, Calvin Freedman & David Dryden  
 7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebery and                David Dryden  
 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy   Robinson, Kim Robbins, Kevin Musto,   Maryanne Holzapfel and David Dryden  
8.0    Board Correspondence  
9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia       Kluger  
10.0 Newsletter Updates  
11.0 Other Business before the Board (for discussion only)  
12.0 Public Comments  
13.0 Next Meeting – August 21, 2013  
14.0 Adjournment  
Please Take Note:  To assure consideration of an application at a meeting, the Board office must receive all of these items no later than 4:30 p.m. ten full working days before the meeting date: 
• Completed, signed and notarized application form, 
• Fee payment, and 
• All required documentation. A final amended agenda will be published to reflect any items received after the original agenda is posted.    
Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum. Pursuant to 29 Delaware Code , Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however, such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the body’s meeting. 
MEMBERS:  PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us  IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING.  THANK YOU. 

Friday, March 15, 2013

ILLINOIS STATE BOARD OF PHARMACY March 13, 2013 Meeting Agenda


M E M O R A N D U M
TO: ILLINOIS STATE BOARD OF PHARMACY
Mr. Philip Burgess, R.Ph., Chairperson
Mr. Ned Milenkovich, R.Ph., Vice-Chairperson
Mr. Sudhir Manek, R.Ph., Member
Mr. Gordon John Mazzotti, R.Ph., Member
Mr. Ronald A. Weinert, R.Ph., Member
Ms. Miriam A. Mobley Smith, R.Ph., Member
Dr. Yatin M. Shah, M.D., Member
Mr. Yash V. Patel, R.Ph., Member
FROM: Sandra Dunn, Manager
Health Services Section
DATE: February 20, 2013
RE: BUSINESS MEETING – MARCH 12, 2013
The Illinois State Board of Pharmacy meeting is scheduled to meet at 9:30 a.m., Tuesday,
March 12, 2013, in the Chicago office of the Department of Financial and Professional Regulation,
James R. Thompson Center, 100 West Randolph, 9th Floor, Room 9-031, Chicago, Illinois for the
purpose of conducting a regular business meeting.
Please advise me in advance of the meeting date if you are unable to attend to ensure that a quorum is
present. My telephone number is 217/524-2167. The agenda is attached.
This meeting will be accessible to disabled individuals in compliance with Executive Order #5 and
pertinent state laws upon notification of anticipated attendance. Disabled persons planning to attend and
needing special accommodations should contact me either by telephone or letter, at least five days prior
to the meeting date.
SD
Illinois Department of Financial and Professional Regulation
Division of Professional Regulation
PAT QUINN
Governor
MANUEL FLORES
Acting Secretary
JAY STEWART
Director
Division of Professional Regulation
www.facebook.com/ILDFPR www.idfpr.com http://twitter.com/#!/IDFPR
ILLINOIS STATE BOARD OF PHARMACY
AGENDA
MARCH 12, 2013
I. CHAIRPERSON TIME
A. 9:30 A.M. – Call to Order
B. Board Member, Staff and Guest Introductions
C. Agenda Review
II. OLD BUSINESS
A. Minute Approval – January 8, 2013 (Open)
B. Board Member Update and/or Changes
III. NEW BUSINESS
A. Presentation - OnePoint Patient Care
Peter Speranza, General Counsel
B. Department Updates
C. Pharmacy Technician Renewals
D. Impaired Pharmacist Program
E. Graduation Requirements vs. Commencement Date for
NAPLEX Registration
IV. Legislation Update – Scott Meyers, I.C.H.P.
V. FILE REVIEW
A. Courses of Clinical Instruction
B. Remedial Training
VI. DELIBERATIONS
VII. CLOSED MINUTES APPROVAL – January 8, 2013
VIII. SIGNATURES
IX. ADJOURNMENT
Source found here